Reports Q4 revenue $773.9M, consensus $768.69M. “We demonstrated solid execution during the fourth quarter against a stable to improving macro-environment,” said CEO Liam Kelly. “We once again built upon Teleflex’s growth objectives which resulted in 6.5% constant currency revenue growth for 2023. During the year, we expanded our geographic presence, launched new products, and continued to drive efficiencies throughout the business. In addition, we advanced our capital allocation strategy with the close of the Palette Life Sciences AB acquisition in October, 2023 and our integration activities are progressing well. As we look into 2024, we remain committed to our corporate strategy for durable growth.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TFX:
- Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
- TFX Earnings this Week: How Will it Perform?
- Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
- Teleflex price target raised to $280 from $225 at Piper Sandler
- Teleflex price target raised to $272 from $228 at RBC Capital